Chrysalis Intelligence · Product Codes · PZJ

PZJ · Lynch Syndrome Test System

Immunology · 3 clearances · 3 unique sponsors

Device class
Class II
Regulation 864.1866
Total clearances
3
2021-07-26 → 2023-02-27
Last 12 months
0
Unique sponsors
3
Definition

What is Lynch Syndrome Test System

The Lynch syndrome test system is used to identify loss of DNA mismatch repair proteins or microsatellite instability in tumor tissue from cancer patients for the purpose of identifying patients who may benefit from additional testing for the inherited cancer predisposition Lynch Syndrome
Medical specialty
Immunology
Review panel
PA
Regulation number
864.1866
Implant
N
Life-sustain / support
N
GMP exempt
N
Third-party review
N
Trend

Clearance volume by quarter

Players

Top sponsors in this product code

Sponsor Clearances Last 12 mo Most recent
Promega Corporation 1 0 2021-07-26
Leica Biosystems Newcastle, Ltd. 1 0 2023-02-21
Biocartis NV 1 0 2023-02-27
Reimbursement

Likely billing codes (AI-inferred · verify with billing)

Healthcare providers using this device would typically bill under these HCPCS Level II (alphanumeric) or CPT (5-digit) codes. Mapping inferred from device function by Claude Haiku; official descriptions pulled from the CMS HCPCS April 2026 quarterly file where available. Always verify with billing/coding teams before relying on these.

CodeTypeDescriptionConfidenceRationale
81295 CPT High CPT for microsatellite instability (MSI) testing in tumor tissue
81297 CPT High CPT for mismatch repair gene panel testing (MLH1, MSH2, MSH6, PMS2)
Pulse

Most recent 510(k) clearances

DateK-numberSponsorDevice
2023-02-27 K211181 Biocartis NV Idylla MSI Test
2023-02-21 K213348 Leica Biosystems Newcastle, Ltd. BOND MMR Antibody Panel
2021-07-26 K200129 Promega Corporation OncoMate MSI Dx Analysis System